Chugai Pharmaceutical Hits Day High with Strong 5.26% Intraday Surge

Chugai Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.26% on February 24, 2026. The stock reached an intraday high of JPY 10,220.00, showcasing its strong market activity. This performance stands in contrast to the Japan Nikkei 225, which declined by 1.12% on the same day. Over the past week, Chugai has shown an impressive 8.84% increase, and its one-month performance reflects a robust growth of 22.53%. Year-to-date, the stock has also performed well, matching this monthly growth rate. Notably, Chugai's three-year performance has surged by 182.91%, significantly outpacing the Nikkei 225's 106.4% increase during the same period. The company maintains a solid financial foundation, with a return on equity (ROE) of 22.39% and a low debt-to-equity ratio of -0.47. Chugai's net sales have grown at an annual rate of 11.43%, and its operating profit has increased by 19.46%. With a market capitalization of JPY 13,855,584 million, Chugai Pharmaceutical continues to demonstrate strong fundamentals in the pharmaceuticals and biotechnology sector.